Princess Adila: Her Royal Highness, Her Human Mission
Inside the remarkable journey of Princess Adila bint Abdullah Al Saud. An exclusive interview for CancerWorld. When I entered the room, it felt as though I had stepped into a page from an Arabian fairytale. The room was quiet and…
Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs.…
It’s no longer taboo to suggest that some metastatic breast cancers may be curable
It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the…
NEWS
A Bold Step into Building Africa’s Cancer Atlas
Cancer does not affect all populations equally. For individuals of African descent, whether living on the continent or in the diaspora, cancer often presents at different stages, responds differently to treatment, and is associated with poorer outcomes. Yet, African populations…
CONTENTS
ARTICLES
Empowering Patients in Europe’s New Health Technology Assessment
Across the European Union, cancer patients often wait months, or even years, for access to promising new treatments already approved by the EMA. Now, the EU’s new Health Technology Assessment (HTA) Regulation is introducing a shared framework for evaluating new…
